A Washington state resident succumbed to H5N5 bird flu on November 21, 2025—the world’s first human death from this avian-only strain and the U.S.’s second avian influenza fatality this year—after hospitalization since early November, underscoring a chilling escalation in spillover events amid 70+ domestic cases since 2022. The older adult with comorbidities contracted the virus from a backyard flock of mixed domestic birds—DOH sampling confirmed environmental avian influenza—marking the first U.S. human H5N5 case since February’s Louisiana H5N1 toll.
CDC affirms low public risk—no human-to-human transmission, contacts (100+ health workers) negative—yet WHO’s 1,000+ global cases since 2003 across 25 countries signal diversification, with H5N5’s lung-deep assault echoing Asia’s lethal 2000s patterns sans PB2 E627K mutations for easy human binding. Wild birds spread to poultry/backyards as likely vectors; officials urge flu shots (reducing co-infection mutation odds) and PPE for flocks— “If birds die, don’t touch; call us.”
Bird flu second death 2025 amplifies alarms: 2022’s mammal spread and 2025’s 70 cases (mostly mild dairy workers) hint viral probing, with H5N1 egg hikes and poultry culls persisting. Surveillance ramps: CDC’s streamlined H5 updates and FluView track pediatric rises, while global “chatter” frequency climbs per WHO. For public health sentinels in bird flu H5N5 death November 2025, this fatality isn’t finale—it’s flare: avian anomalies augur adaptation risks, demanding vigilant vaccines and vector vigilance in flu‘s frontier flux.
